Eupraxia Pharmaceuticals Inc. (EPRX)

NASDAQ

$6.69

$-0.63

(-8.61%)

Pre-Market

Eupraxia Pharmaceuticals Inc. (EPRX) Live Price Chart

Last updated: ⁦2026-10-14 09:51:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Eupraxia Pharmaceuticals Inc. (EPRX) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $6.69, with a market capitalisation of $483.66M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $5.25 to $9.32. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$483.66M
Open	$7.29
Day's High	$9.32
Day's Low	$2.20
Previous Close	$7.32
Volume	1.16M
Average Volume	617.10K
P/E Ratio	--
52-Week High	$9.32
52-Week Low	$5.25
Dividend Yield	--
Earnings Date	--

Eupraxia Pharmaceuticals Inc. (EPRX) Pre-Market Stock Price

Eupraxia Pharmaceuticals Inc. (EPRX) is trading at $7.41 in pre-market trading as of 2026-10-13 23:54:00, up 1.28% ($0.09) from the previous close of $7.32

Pre-market trading shows how investors are pricing EPRX before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Eupraxia Pharmaceuticals Inc. (EPRX) 7-Day Stock Price Change

Over the past seven days, Eupraxia Pharmaceuticals Inc. (EPRX) moved from $7.75 to $6.69, representing a decline of 13.57% ($1.05).

The stock traded between $6.62 and $8.07 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 1.10 million shares, down versus the previous seven-day period, indicating lower trading activity.

EPRX 52-Week Price Position

Position in Range: 35.5%

52W Low$5.25

52W High$9.32

EPRX is currently trading at $6.69, placing it 35.5% of the way from its 52-week low of $5.25 to its 52-week high of $9.32. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Eupraxia Pharmaceuticals Inc. (EPRX)?

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with unmet medical needs. Currently, the company has two distinct clinical development programs, one targeting EoE and the second targeting chronic Osteoarthritis pain in the knee and has completed a Phase 2b clinical trial with EP-104IAR in knee OA.

Eupraxia Pharmaceuticals Inc. Information

Employees	49
Exchange	NASDAQ
Company Website	https://www.eupraxiapharma.com

How to Buy Eupraxia Pharmaceuticals Inc. (EPRX) Stock on MEXC

Eligible investors can buy real shares of Eupraxia Pharmaceuticals Inc. (EPRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for EPRX and Place Your Order

Open the RealStocks trading page and search for EPRX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Eupraxia Pharmaceuticals Inc. (EPRX) stock price today?

Eupraxia Pharmaceuticals Inc. (EPRX) is currently trading at $ 6.69, down 8.55% ($0.63) from the previous close of $ 7.32. Intraday prices update in real time during regular trading hours.

2.Is EPRX stock going up or down today?

As of 2026-10-13 23:54:00, EPRX is trading at $ 6.69, down 8.55% ($0.63) from its previous close of $ 7.32. The stock has traded between $ 2.20 and $ 9.32 during today’s regular session. Past price movements do not guarantee future results.

3.What is EPRX pre-market price?

As of 2026-10-13 23:54:00, EPRX is trading at $ 7.41 in pre-market trading, up 1.28% ($0.09) from the previous close of $ 7.32. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is EPRX after-hours price?

As of 2026-10-13 23:54:00, EPRX is trading at $ 6.78 in after-hours trading, down 7.38% ($0.54) from the regular-session close of $ 7.32. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is EPRX stock trading now?

EPRX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does EPRX sit relative to its 52-week high and low?

Over the past 52 weeks, EPRX has traded between a low of $ 5.25 and a high of $ 9.32. At $ 6.69, the stock is positioned 35.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Eupraxia Pharmaceuticals Inc. in?

Eupraxia Pharmaceuticals Inc. (EPRX) operates in the -- sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Eupraxia Pharmaceuticals Inc.'s market capitalisation and where is it listed?

Eupraxia Pharmaceuticals Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 483.66M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is EPRX valued in terms of P/E ratio and EPS?

EPRX trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Eupraxia Pharmaceuticals Inc. pay a dividend?

Eupraxia Pharmaceuticals Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.